Asthma can cause changing breathlessness, nighttime cough or exercise symptoms—even when nobody hears a wheeze. Breathing tests matter more than an isolated laboratory result.
Idei principale
- Asthma symptoms include variable wheezing, breathlessness, chest tightness and cough; having 1 symptom does not establish the diagnosis.
- Nighttime waking from asthma symptoms even once in the previous 4 weeks is a reason to review symptom control under the GINA assessment framework.
- Cough without wheezing can occur in cough-variant asthma, but cough lasting more than 8 weeks in adults has several other possible causes.
- Spirometry response of at least 12% and 200 mL in adult FEV1 after a bronchodilator supports variable airflow limitation under commonly used asthma criteria.
- Peak-flow variability o medie de peste 10% pe parcursul a 2 săptămâni susține diagnosticul de astm la adulți conform criteriilor GINA; NICE folosește un prag de diagnostic diferit.
- FeNO de cel puțin 50 ppb la adulți susține inflamația de tip 2 a căilor respiratorii în contextul clinic adecvat, dar o valoare scăzută a FeNO nu exclude astmul.
- Eozinofilele din sânge peste 0.5 × 10^9/L poate indica alergie, astm sau alte afecțiuni; un rezultat sanguin, singur, nu poate confirma astmul.
- Semne de urgență respiratorie includ incapacitatea de a vorbi normal, epuizarea, confuzia, buzele albastre sau cenușii ori răspunsul slab la medicamentul de ameliorare prescris; nu așteptați rezultatul unui test.
What are the early signs of asthma?
Asthma symptoms sunt episoade variabile de respirație șuierătoare, dificultăți de respirație, senzație de constricție toracică sau tuse, adesea mai intense noaptea sau după efort; astmul poate apărea fără respirație șuierătoare evidentă. Spirometria și monitorizarea debitului expirator de vârf ajută la evidențierea limitării variabile a fluxului de aer, în timp ce analizele de sânge, singure, nu pot confirma astmul. Dificultățile severe de respirație, confuzia sau lipsa de efect a medicamentului de ameliorare impun asistență medicală de urgență.
Semnele timpurii ale astmului implică adesea o schimbare față de modul obișnuit în care respirați, nu un simptom constant: o plimbare familiară devine mai dificilă, râsul declanșează tusea sau o răceală lasă simptome toracice neobișnuit de prelungite. Notați tiparul timp de 2 săptămâni dacă simptomele sunt ușoare și stabile, dar solicitați o evaluare mai devreme dacă respirația se înrăutățește.
Intervalele fără simptome nu exclud astmul. O persoană poate avea 3 zile fără probleme, urmate de senzație de constricție după ce face mișcare în aer rece, deoarece sensibilitatea căilor respiratorii și expunerea variază; în mod similar, o examinare normală a toracelui între episoade nu poate demonstra căile respiratorii funcționează întotdeauna normal.
O persoană ipotetică de 34 de ani ar putea spune că tușește după alergare, s-a trezit de 2 ori într-o săptămână și se simte perfect bine la serviciu. Această combinație ridică mai multe suspiciuni decât o singură tuse izolată, dar următorul pas este anamneza clinică și testarea obiectivă — nu presupunerea că ameliorarea după folosirea unui inhalator împrumutat dovedește astmul.
Kantesti este o Analizor de teste de sânge AI care ajută la explicarea rezultatelor de laborator ce oferă indicii, nu la înlocuirea măsurării fluxului de aer. Articolul nostru și scopul nostru clinic diferențiază interpretarea analizelor de laborator de diagnosticul respirator: nici măcar 2 seturi de analize de laborator normale nu pot exclude o afecțiune respiratorie intermitentă.
Why are asthma symptoms at night more noticeable?
Simptomele astmului noaptea pot deveni mai evidente deoarece calibrul căilor respiratorii și activitatea inflamatorie urmează ritmuri zilnice, iar alergenii din dormitor sau refluxul pot constitui factori declanșatori suplimentari. Conform evaluării controlului simptomelor GINA 2025, orice trezire nocturnă asociată astmului în ultimele 4 săptămâni necesită atenție.
Tusea nocturnă nu este automat un semn de astm. Tusea după ce vă întindeți, însoțită de gust acru sau regurgitare, sugerează un posibil alt factor contribuitor, iar articolul nostru tiparele simptomelor de reflux explică de ce momentul apariției simptomelor este relevant; 2 afecțiuni pot coexista, astfel că identificarea refluxului nu explică neapărat fiecare episod de dificultăți de respirație.
Trezirile repetate oferă mai multe informații decât simpla oră la care au loc. Notați numărul trezirilor pe parcursul a 7 nopți, dacă ați simțit constricție toracică sau dificultăți de respirație și dacă medicamentul de ameliorare prescris a avut efect; tusea la miezul nopții după masă diferă de trezirea în zori cu dificultăți la expir.
Strategia GINA 2025 evaluează simptomele diurne, trezirile nocturne, limitarea activității și, după caz, utilizarea medicamentelor de ameliorare cu acțiune scurtă, pe parcursul a 4 săptămâni. O persoană care doarme prost din cauza astmului nu ar trebui să interpreteze o valoare normală a oxigenului măsurată ziua drept dovadă a unui control bun, deoarece saturația de oxigen nu măsoară variabilitatea căilor respiratorii.
Un jurnal ținut în dormitor poate ajuta la deosebirea expunerii de o simplă coincidență: notați dacă simptomele apar acasă, în afara casei sau după schimbarea lenjeriei, pe parcursul unei perioade de 2 săptămâni. Evitați să vă expuneți dinadins din nou unui factor declanșator suspectat; trezirile persistente justifică reevaluarea tratamentului și a tehnicii de utilizare a inhalatorului, nu doar adăugarea unor perne.
Can asthma cause a cough without wheezing?
Tusea astmatică fără respirație șuierătoare este posibilă, în special în astmul cu variantă tusivă, în care tusea poate fi principalul simptom, iar spirometria de rutină poate fi normală. La adulți, o tuse care durează peste 8 săptămâni necesită evaluarea altor cauze, precum și a astmului.
Atât astmul cu variantă tusivă, cât și bronșita eozinofilică non-astmatică pot provoca tuse cronică asociată cu inflamația eozinofilică a căilor respiratorii. Distincția este importantă, deoarece celei de-a doua afecțiuni îi lipsesc, de regulă, limitarea variabilă a fluxului de aer sau hiperreactivitatea bronșică caracteristice astmului; un număr crescut de eozinofile nu poate distinge, de unul singur, între aceste 2 diagnostice.
A normal initial breathing test does not close the investigation when the symptom pattern remains convincing. Clinicians may repeat spirometry during symptoms or consider a supervised bronchial challenge, whereas coughing spells with vomiting or a relevant contact history may need whooping cough testing with attention to how many weeks have elapsed.
Medication review can identify an overlooked explanation for cough. An ACE inhibitor used for blood pressure can cause a dry cough even after months of treatment, so bring a complete medication list rather than focusing only on drugs started within the previous 2 weeks; do not stop prescribed treatment without advice.
The absence of wheezing has 2 very different meanings: mild asthma may produce no audible wheeze, while a severe attack may become quiet because too little air is moving. Quiet breathing combined with exhaustion, difficulty speaking or worsening breathlessness is an emergency—not evidence that the attack has ended.
How do exercise-triggered asthma symptoms behave?
Exercise-induced bronchoconstriction causes temporary airway narrowing during or after exercise, often becoming most noticeable within about 5–10 minutes after stopping. Exercise symptoms alone do not prove asthma, because laryngeal obstruction, anaemia and other conditions can also limit breathing.
Exercise-related laryngeal obstruction often causes throat tightness or noisy breathing during inhalation at peak effort, then settles relatively quickly after stopping. Bronchoconstriction more often affects expiration and recovery; these are clues rather than absolute rules, and the 2 conditions can occur in the same person.
A supervised exercise challenge measures airflow rather than relying on whether exercise feels difficult. A fall in FEV1 of more than 10% and more than 200 mL after exercise supports asthma in adults under GINA's diagnostic framework; local protocols and criteria for exercise-induced bronchoconstriction may differ.
Reduced exercise tolerance without cough, tightness or variable wheeze deserves a broader assessment. Our iron stores in athletes guide explains why a hypothetical runner with ferritin of 12 ng/mL may need an iron assessment, but that result would not explain away independently documented airway narrowing.
An exercise diary should include intensity, weather and whether symptoms peak during activity or 10 minutes afterward. Once assessed, many people can remain active using a clinician-agreed plan; avoid testing your limits during an unstable period or repeatedly using a reliever without reviewing the underlying treatment.
Which triggers commonly bring on asthma symptoms?
Asthma triggers include respiratory viruses, pollen, dust mites, animal allergens, smoke, air pollution, cold air and exercise. A 2-week exposure diary can suggest patterns, but a suspected trigger is not the same thing as a confirmed allergy or a diagnosis of asthma.
Allergy testing identifies sensitisation, not necessarily the cause of every breathing episode. A positive specific IgE result to 1 allergen becomes clinically useful when exposure reliably matches symptoms; our testarea alergiilor la componente guide explains why more detailed panels still require a relevant history.
Damp buildings can worsen respiratory symptoms through several mechanisms, including allergen exposure and irritation. There is no single laboratory panel that establishes 'mould-related asthma'; our mould testing limitations distinguish targeted allergy assessment from unsupported broad testing, and symptoms should be evaluated even when 1 panel is normal.
Work-related asthma can appear after months or years of exposure and may improve on weekends or holidays. Record work tasks and breathing measurements across both work and non-work days for an occupational assessment; a specialist may need more than the standard 2-week diagnostic diary, and intentional exposure challenges are unsafe.
Some beta-blockers, including certain eye drops, can worsen bronchoconstriction, while aspirin or other NSAIDs trigger symptoms in a susceptible subgroup rather than everyone with asthma. Review all medications, including over-the-counter products, during 1 appointment; do not stop cardiovascular drugs or attempt a home aspirin challenge.
What else can look like asthma?
Asthma-like symptoms can result from reflux, upper-airway disorders, COPD, anaemia, cardiac disease or respiratory infection. At least 2 separate conditions may contribute, so persistent symptoms despite appropriate asthma treatment should prompt reassessment rather than automatic dose escalation.
Wheeze limited to one area or symptoms beginning suddenly after choking suggest focal airway obstruction rather than typical diffuse asthma. The finding deserves clinical assessment, particularly in a child; a single persistent wheeze has a different diagnostic meaning from episodes that change with several unrelated triggers.
Fixed obstruction on repeated spirometry does not automatically mean COPD, because longstanding asthma can also leave persistent airflow limitation. Smoking history, age and previous lung disease help distinguish causes, while early emphysema or a strong family history may justify alpha-1 antitrypsin assessment rather than assuming 1 diagnostic label explains everything.
Recurrent chest infections, poor growth or a chronic productive cough in a young person should widen the investigation. A sweat chloride result of at least 60 mmol/L supports cystic fibrosis in the appropriate diagnostic setting; values of 30–59 mmol/L require further evaluation rather than being treated as an asthma result.
New breathlessness with chest pressure, fainting or inability to lie comfortably needs timely assessment for non-asthma causes. Even 1 abrupt episode of unexplained breathlessness can be urgent, and attributing symptoms to anxiety before checking relevant respiratory and cardiac possibilities risks missing a treatable condition.
How does spirometry support an asthma diagnosis?
Spirometry measures airflow, including FEV1 and FVC, and can show obstruction that improves after a bronchodilator. An adult FEV1 increase of at least 12% and 200 mL supports variable airflow limitation under commonly used asthma criteria, but a negative test does not exclude intermittent asthma.
The FEV1/FVC ratio helps identify obstruction, but interpretation should use an age-appropriate lower limit of normal rather than applying 0.70 to every patient. The European Respiratory Society adult diagnostic guideline recommends spirometry and bronchodilator testing within a structured assessment, followed by additional tests when necessary (Louis et al., 2022).
Consider a hypothetical result: FEV1 rises from 1.90 L to 2.18 L after the test medication. The increase is 280 mL and 14.7% of the starting value, meeting the commonly used adult reversibility criterion; the finding supports asthma when the history fits, but it is not a diagnosis detached from clinical context.
Guidelines and laboratory reporting standards do not always express reversibility in the same way. NICE NG245 also accepts an adult FEV1 increase of at least 10% of predicted normal; if predicted FEV1 is 3.40 L, that same 280 mL improvement is only 8.2% of predicted, explaining why 2 reporting conventions can produce different flags.
Testing quality matters: spirometry usually seeks at least 3 acceptable manoeuvres, and adult repeatability commonly requires the best FEV1 values to be within 150 mL. Our breathlessness laboratory guide explains complementary investigations, but no laboratory interpretation can compensate for an unreliable breathing manoeuvre.
How can a peak-flow diary help diagnose asthma?
Peak-flow monitoring can document variable breathing when spirometry is unavailable or initially inconclusive. GINA uses average daily variability above 10% in adults and above 13% in children over 2 weeks as supportive evidence; NICE NG245 uses a 20% diagnostic threshold in its pathway.
Use the same meter and technique each time, usually measuring morning and evening as instructed. Perform 3 blows per session and record the highest acceptable reading in L/min; note symptoms and medication timing, because taking a bronchodilator before one session but not the other can distort the comparison.
Daily variability can be calculated as the highest minus the lowest reading divided by their mean, multiplied by 100. If a hypothetical day's readings are 380 and 460 L/min, variability is 80/420 × 100, or 19.0%; the diagnostic assessment uses the average across the monitoring period, not that single day's percentage.
Peak-flow action zones and diagnostic variability answer different questions. A personalised plan may use at least 80% of personal best, 50–79%, and below 50% to guide action, whereas diagnosis examines fluctuations over time; a low personal best should not be accepted as normal without checking technique and clinical status.
Kantesti este o platforma de interpretare analize sange AI, not a service for confirming asthma from a 2-week breathing diary. Our AI report safety checks explain why readers should distinguish a recorded value, an automated explanation and a clinician's diagnosis—particularly when different guidelines use different thresholds.
What do FeNO and eosinophils tell you about asthma?
FeNO measures nitric oxide in exhaled breath, while blood eosinophils measure an inflammatory cell population; both can support assessment of type 2 asthma. NICE NG245 uses FeNO of at least 50 ppb in adults and at least 35 ppb in children aged 5–16 within its diagnostic pathways.
The NICE/BTS/SIGN 2024 guideline allows an elevated blood eosinophil count above the laboratory reference range or FeNO of at least 50 ppb to establish an adult diagnosis within its suggestive-history pathway. This does not mean a blood test alone confirms asthma: the recommendation depends on clinical assessment, and GINA places greater emphasis on documenting variable airflow limitation.
A low FeNO reading does not rule out asthma, particularly after inhaled corticosteroid treatment or in non-type-2 disease. Allergic rhinitis can raise FeNO without proving lower-airway asthma, so a hypothetical reading of 60 ppb with nasal symptoms but no compatible breathing history needs a different interpretation from 60 ppb with recurrent nocturnal tightness.
Eosinophil counts above 0.5 × 10^9/L, equivalent to 500 cells/µL, commonly attract attention, although laboratories use different upper limits. Our high eosinophil interpretation explains why persistent counts of at least 1.5 × 10^9/L require broader evaluation for medications, parasites and other disorders—not simply a stronger asthma label.
Steroid timing can change both FeNO and eosinophil results, sometimes making 2 tests taken weeks apart look inconsistent. Our interpretare clinică support reporting such limitations; tell the clinician when you last used inhaled or oral steroids, but never stop treatment just to make a test more likely to turn positive.
Why can't blood tests alone confirm asthma?
Blood tests alone cannot confirm asthma because they do not demonstrate variable airflow limitation or reliably distinguish asthma from every alternative cause of cough. Even 1 markedly abnormal eosinophil or IgE result needs a compatible history and an appropriate diagnostic pathway.
Total IgE and allergen-specific IgE are different measurements: one reflects an overall antibody concentration, while the other tests sensitisation to selected allergens. There is no universal total-IgE cutoff that diagnoses asthma across adults and children; a positive result to 1 allergen may explain sensitisation without proving that exposure causes wheeze.
A CBC may identify anaemia that contributes to breathlessness, and selected inflammatory tests may help assess a suspected infection. Our WBC și CRP explains why these markers can disagree; an elevated CRP of 25 mg/L is not an asthma threshold and cannot independently determine whether antibiotics are needed.
Kantesti AI can help readers compare eosinophil counts, haemoglobin and other reported markers, but it cannot establish variable airflow limitation from a laboratory PDF. A hypothetical eosinophil change from 0.62 to 0.18 × 10^9/L after steroid treatment may reflect treatment exposure rather than the disappearance of asthma.
Routine asthma diagnosis does not require ordering every available inflammatory marker. Bring existing results and a medication timeline covering at least the previous 2 weeks; clinicians can then select tests for a specific question, such as anaemia, allergy or treatment planning, instead of treating a large panel as a substitute for breathing assessment.
Which breathing warning signs require emergency care?
Apelați imediat serviciile de urgență for severe breathlessness, inability to speak normally, blue or grey lips, confusion, drowsiness, exhaustion or a prescribed reliever that is not helping. If available, peak flow below 50% of personal best or oxygen saturation of 92% or less with acute symptoms adds urgency; do not wait for either measurement.
A quiet or 'silent' chest during worsening breathing can indicate critically reduced air movement, not recovery. Peak flow below 33% of personal best is a life-threatening feature in UK acute-asthma frameworks, but inability to obtain a reading because of severe breathlessness is itself concerning; call the local emergency number, such as 999 or 112 where applicable.
While help is coming, sit upright and use your prescribed reliever according to your written action plan or emergency-dispatch instructions. Do not drive yourself, and do not delay the call to perform repeated peak-flow tests; even 1 episode of confusion or marked exhaustion can signal that self-management is no longer safe.
An oxygen reading does not measure carbon dioxide, and home devices can be inaccurate because of movement, cold fingers or other factors. Our arterial gas interpretation explains why a normal or rising PaCO2 near or above 45 mmHg during severe acute asthma can concern clinicians when vigorous breathing would usually lower it.
Sudden breathlessness with chest pain, coughing up blood or unilateral leg swelling may indicate another emergency; our urgent leg clot signs explain that connection. Breathing difficulty with tongue or throat swelling after an exposure can be anaphylaxis: use a prescribed adrenaline auto-injector immediately and call emergency services, because 1 asthma inhaler does not replace anaphylaxis treatment.
How are asthma symptoms assessed in children?
Children's asthma symptoms may include nighttime cough, wheeze, reduced play or breathlessness rather than a clear description of chest tightness. Objective testing is often possible from about age 5, while younger children usually need a pattern-based assessment and monitored treatment response.
Preschool viral wheeze is not identical to established persistent asthma. Clinicians consider whether symptoms occur only during colds or also between illnesses, along with allergy history and family risk; 2 children who wheeze with the same virus can have different longer-term patterns, so a permanent label should not rest on one episode.
A treatment trial in a child younger than 5 may be assessed over approximately 8–12 weeks under NICE guidance, depending on the presentation. Improvement needs to be interpreted alongside adherence, device technique and natural recovery from a virus; a treatment response is useful evidence, but it is not an isolated laboratory-style confirmation.
Children's spirometry requires age-appropriate interpretation and coaching, not adult thresholds pasted onto smaller lungs. GINA uses an FEV1 increase of at least 12% of predicted in children as a supportive bronchodilator criterion, and a technically poor test may need repetition even if the report prints a reassuring percentage.
Noastre children's laboratory safety guide explains why age-specific ranges matter without replacing respiratory assessment. In a child, marked chest recession, inability to drink or speak normally, unusual sleepiness or worsening breathing warrants urgent help; even 1 such sign outweighs a normal previous test.
What should you bring to an asthma assessment?
Prepare for an asthma assessment by bringing your symptom pattern, medication list, inhaler devices and any previous breathing or laboratory results. A 2-week diary of symptoms, exposures and clinician-requested peak-flow readings is often more useful than a long list of unrelated tests.
Ask the testing service which inhalers, if any, should be withheld and for how long before spirometry. Instructions vary by medication and test purpose, so do not assume a universal 12-hour rule; if symptoms worsen while following preparation instructions, use needed treatment and contact the service rather than prioritising an ideal test.
Bring the actual inhaler and spacer so a clinician can observe technique rather than relying on a description. Different devices require different inhalation patterns, and 1 correct demonstration can reveal why a prescribed treatment seemed ineffective; poor technique can look like resistant disease even when the medication choice is appropriate.
Kantesti este o Instrument de analiză a analizelor de sânge bazat pe AI that can help explain accompanying laboratory reports while the clinician evaluates breathing symptoms. Our Ghid pentru tehnologia AI describes the interpretation workflow, but an estimated processing time of about 60 seconds should never be confused with the time needed to establish a respiratory diagnosis.
Share only the information needed for the assessment, particularly when organising results for another family member. Our informații despre confidențialitate și date explains handling considerations; keep symptom diaries and original reports available for clinical review, and do not let uploading 1 document delay urgent care or a necessary breathing appointment.
Research publications and evidence behind asthma testing
Asthma diagnostic evidence comes primarily from respiratory guidelines and studies of airflow, airway responsiveness and inflammatory markers. The 3 external references below directly support this article; the 2 Zenodo laboratory guides are separate educational resources and are not studies validating asthma diagnosis.
GINA's 2025 strategy links a characteristic symptom history with evidence of variable expiratory airflow limitation, while the 2024 NICE/BTS/SIGN guideline specifies a different sequence of objective tests. The European Respiratory Society adult guideline supplies a third structured approach (Louis et al., 2022); comparing all 3 helps explain why clinicians may reasonably order tests in different sequences.
materialele Kantesti RDW și ghidul pentru celulele roșii din sânge provides background when a CBC raises a separate question about anaemia and breathlessness. Its Zenodo DOI identifies that publication, not proof that RDW diagnoses asthma; even 2 abnormal red-cell indices must be interpreted as haematology findings rather than measurements of airway narrowing.
The de interpretare a raportului renal addresses BUN, creatinine and clinical context rather than asthma symptoms. Its separate Zenodo DOI is included for publication transparency, and neither of these 2 laboratory guides establishes the sensitivity, specificity or effectiveness of an asthma diagnostic pathway.
Noastre standarde de conținut medical distinguish guideline-supported facts from educational examples and product descriptions. Kantesti does not claim that these 2 DOI resources validate asthma detection; uncertain symptoms need clinical assessment, and emergency breathing warning signs require immediate action regardless of how recently a report was interpreted.
Întrebări frecvente
Care sunt primele semne ale astmului la adulți?
Primele semne ale astmului la adulți includ adesea dificultăți de respirație fluctuante, senzație de constricție toracică, respirație șuierătoare sau tuse care se agravează noaptea ori după efort fizic. O perioadă fără simptome nu exclude astmul, deoarece limitarea fluxului de aer poate varia de la o zi la alta. Un jurnal al simptomelor ținut timp de 2 săptămâni poate ajuta clinicianul să identifice tipare atunci când simptomele sunt ușoare și stabile. Pentru susținerea diagnosticului este necesară spirometria sau o altă testare obiectivă adecvată, iar agravarea respirației trebuie evaluată mai devreme.
Poți avea astm fără respirație șuierătoare?
Astmul poate apărea fără wheezing audibil, în special când tusea este simptomul principal sau când simptomele lipsesc în timpul examinării. Tusea la adulți care durează mai mult de 8 săptămâni necesită evaluare pentru astm și alte cauze, inclusiv reflux, efecte ale medicamentelor și bronșită eozinofilică non-astmatică. O spirometrie inițială normală poate duce la repetarea testării sau la un test de provocare bronșică supravegheat, dacă suspiciunea persistă. Absența zgomotelor respiratorii în timpul unei dispnei severe este altceva: poate indica un flux de aer periculos de redus și necesită ajutor de urgență.
De ce se agravează astmul noaptea?
Asthma can worsen at night because airway function follows daily rhythms and bedroom allergens or reflux may add triggers. GINA's symptom-control assessment treats any asthma-related nighttime waking in the previous 4 weeks as a reason to review control. Record awakenings, breathing symptoms and prescribed reliever use rather than assuming every nighttime cough is asthma. Repeated waking should prompt a clinical review, while severe breathing difficulty requires emergency care.
Poate un test de sânge să indice dacă aveți astm?
Un test de sânge, de unul singur, nu poate confirma astmul, deoarece nu demonstrează o limitare variabilă a fluxului de aer și nu exclude toate celelalte cauze ale simptomelor respiratorii. Eozinofilele peste 0,5 × 10^9/L pot apărea în astm, alergii, în urma administrării unor medicamente sau în alte afecțiuni. NICE NG245 permite stabilirea unui diagnostic la adulți pe baza eozinofilelor crescute, în cadrul unui algoritm aplicabil atunci când istoricul medical este sugestiv, însă acesta este un algoritm clinic — nu interpretarea unui rezultat izolat al unei analize de sânge. În funcție de tabloul clinic și de recomandările locale, medicii pot utiliza și spirometria, FeNO, monitorizarea debitului expirator de vârf sau testul de provocare bronșică.
Poți avea astm cu spirometrie normală?
Spirometria normală nu exclude astmul, deoarece îngustarea căilor respiratorii poate fi intermitentă sau suprimată de tratament. Clinicienii pot repeta spirometria în timpul simptomelor, pot recomanda măsurarea debitului expirator de vârf de două ori pe zi timp de 2 săptămâni sau pot solicita efectuarea unui test de provocare bronșică sub supraveghere. O ameliorare a FEV1 la adulți de cel puțin 12% și 200 mL după administrarea unui bronhodilatator susține existența variabilității conform criteriilor utilizate în mod obișnuit. Instrucțiunile de pregătire depind de medicament și de test, așadar nu întrerupeți niciodată utilizarea unui inhalator fără recomandări medicale specifice.
Când trebuie tratate simptomele astmului ca o urgență?
Simptomele astmului necesită ajutor de urgență atunci când respirația este foarte dificilă, persoana nu poate vorbi normal, devine epuizată sau confuză, buzele devin albastre sau cenușii ori inhalatorul de salvare prescris nu ajută. Un debit expirator maxim sub 50% din valoarea personală maximă sau o saturație a oxigenului de 92% sau mai mică în prezența simptomelor acute sporesc motivele de îngrijorare, dar nu trebuie să așteptați efectuarea măsurătorilor pentru a acționa în caz de urgență. Stați în poziție verticală, sunați la numărul local de urgență și folosiți inhalatorul de salvare prescris conform planului scris sau instrucțiunilor operatorului. Nu conduceți singur și considerați dispariția zgomotelor respiratorii în timp ce dificultățile de respirație se agravează un semnal de alarmă, nu un motiv de liniștire.
Aflați cum se citesc analizele de sânge
Încărcați buletinul de analize, iar AI-ul Kantesti explică fiecare biomarker în limbaj simplu, în câteva secunde. Folosit de peste 2 milioane de persoane din întreaga lume.
Referințe
- Klein, T., Mitchell, S., & Weber, H. (2026). Analiza de sânge RDW: ghid complet pentru RDW-CV, MCV și MCHC. Kantesti AI Medical Research. DOI
- Klein, T., Mitchell, S., & Weber, H. (2026). Explicarea raportului BUN/Creatinină: Ghid pentru testul funcției renale. Kantesti AI Medical Research. DOI
- Global Initiative for Asthma (2025). Global Strategy for Asthma Management and Prevention. GINA Strategy Report.
- National Institute for Health and Care Excellence, British Thoracic Society, and Scottish Intercollegiate Guidelines Network (2024). Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN). NICE Guideline NG245.
- Louis R et al. (2022). European Respiratory Society guidelines for the diagnosis of asthma in adults. European Respiratory Journal. DOI
- 2M+Teste analizate
- 127+Țări
- 100+Limbi
Despre echipa medicală
Semnale de încredere E-E-A-T
Experienţă
Revizuire clinică condusă de medici a fluxurilor de lucru pentru interpretarea analizelor.
Expertiză
Focalizare pe medicina de laborator asupra modului în care biomarkerii se comportă în context clinic.
Autoritate
Revizuit medical de Dr. Thomas Klein, cu contribuții din partea Dr. Sarah Mitchell și Prof. Dr. Hans Weber.
Încredere
Interpretare bazată pe dovezi, cu căi clare de urmărire pentru a reduce alarmele.
Declinare a răspunderii medicale
Acest articol are doar scop educațional și nu constituie sfat medical. Consultă întotdeauna un furnizor calificat de servicii medicale pentru decizii privind diagnosticarea și tratamentul.
Publicat · Contactați echipa editorială
Publicat de Kantesti Ltd, înregistrată în Anglia și Țara Galilor, numărul companiei. 17090423, Londra, Regatul Unit.
